|
|
|
|
|
Received: 06 September 2021
|
|
|
|
|
|
| [1] |
Zak A,Zeman M,Slaby A,et al.Xanthomas:clinical and pathophysiological relations[J].Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2014,158(2):181-188.
|
| [2] |
罗 彤,霍 鸣,吴 昊.不同方式治疗眼睑黄斑瘤的临床观察[J].实用医学杂志,2014,30(2):326.
|
| [3] |
Wang K Y,Hsu K C,Liu W C,et al.Relationship between xanthelasma palpebrarum and hyperlipidemia[J].Ann Plast Surg,2018,80(2S Suppl 1):84-86.
|
| [4] |
王秀君,马洪棉.邢台市城乡居民眼睑黄色瘤流行情况调查[J].职业与健康,2010,26(14):1616-1617.
|
| [5] |
Govorkova M S,Milman T,Ying G S,et al.Inflammatorymeditors in xanthelasma palpebrarum:histopatholgic and immunohistochemical study[J].Ophthalmic Plast Reconstr Surg,2018,34(3):225-230.
|
| [6] |
Dey A,Aggarwal R,Dwivedi S.Cardiovascular profile of xanthelasma palpebrarum[J].Bio Med Research Int,2013(2013) :932863.
|
| [7] |
Pandhi D,Gupta P,Singal A,et al.Xanthelasma palpebrarum:a marker of premature atherosclerosis(risk of atherosclerosis inxanthelasma)[J].Postgrad Med J,2012,88(1038):198-204.
|
| [8] |
Christoffersen M,Tybjaerg H A.Visible aging signs as risk markers for ischemic heart disease:epidemiology,pathogenesis and clinical implications[J].Ageing Res Rev,2016,25(1):24-41.
|
| [9] |
罗东升,潘 宁,熊俊浩,等.睑黄瘤切除联合上睑松弛成形术的临床研究[J].四川医学,2011,32(11):1700-1702.
|
| [10] |
Simoes P,Vivian W,Isabella O,et al.Xanthelasmapalpebrarum after hyaluronic acid injection in the lower eyelid:A case report and review of the literature[J].J Cosmet Dermatol,2021,20(9):2750-2752
|
| [11] |
Nguyen A H,Vaudreuil A M,Huerter C J.Systematic review of laser therapy in xanthelasma palpebrarum [J].Int J Dermatology,2017,56(3):47-55.
|
| [12] |
Cannon P S,Ajit R,Leatherbarrow B.Efficacy of trichloroacetic acid(95%) in the management of xanthelasma palpebrarum[J].Clin Exp Dermatol ,2010,35(8):845-848.
|
| [13] |
韩书丹,干亚丹.液氮冷冻和三氯醋酸治疗睑黄瘤的效果分析[J]. 现代实用医学,2015,25(8):922-923.
|
| [14] |
路 程,彭维海,金洪娟,等.眼轮匝肌皮瓣联合重睑术修复老年人上睑睑黄瘤的疗效[J].中国老年学杂志,2014,34(8):4366-4367.
|
|
|
2022, Vol. 33 
